mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |